Sagimet Biosciences (SGMT) Accumulated Expenses (2023 - 2024)
Sagimet Biosciences (SGMT) has 2 years of Accumulated Expenses data on record, last reported at $995000.0 in Q3 2024.
- For Q3 2024, Accumulated Expenses rose 44.41% year-over-year to $995000.0; the TTM value through Sep 2024 reached $995000.0, up 44.41%, while the annual FY2023 figure was $2.7 million, N/A changed from the prior year.
- Accumulated Expenses reached $995000.0 in Q3 2024 per SGMT's latest filing, up from $657000.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $2.7 million in Q4 2023 and bottomed at $177000.0 in Q2 2023.